This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. Department of Health and Human Services, to Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is part of NIDA's Drug Manufacturing and Formulation Program (DMFP) and is for small-scale testing of convergent route processes. The contract has a ceiling value of $942,363.89 and does not have a set-aside...
This federal contract award is for the Drug Manufacturing and Formulation Program (DMFP) Task Order #01: Performance Activity, issued by the National Institute on Drug Abuse, a civilian agency. The $515,658.99 cost-plus-fixed-fee contract was awarded on January 15, 2015 to the prime contractor MRIGlobal, doing business as Midwest Research Institute, a 501(c)(3) non-profit organization. The contract involves technical support for the DMFP program and includes de-obligating unexpended and expiring...
This is a Cost Plus Award Fee delivery order under a $1,283,149.00 contract awarded by the National Institute of Neurological Disorders and Stroke, a civilian agency, to Mriglobal (also known as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ, and the task is for the PADERI HEAL PROJECT-IHP-102. There is no set-aside designation for this award. Mriglobal is the prime...
This is a $2,426,151.00 cost-plus-fixed-fee delivery order awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to MRI Global, doing business as Midwest Research Institute, a non-profit research organization. The order is part of the Drug Manufacturing and Formulation Program (DMFP) indefinite delivery/indefinite quantity (IDIQ) contract. The contract does not have a set-aside designation and is for analytical services related to the...
This is a delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to MRIGlobal, a not-for-profit research organization also known as Midwest Research Institute. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ contract vehicle and has a potential value of $1,535,538.00. The contract does not have a set-aside designation. Under this contract,...
This is a $99,500.00 delivery order contract awarded to Mriglobal, also doing business as Midwest Research Institute, by the Department of Health and Human Services' National Institutes of Health National Institute on Aging. The contract is for drug toxicity testing services, with a period of performance through July 31, 2024. The contract is not set aside for any small business program. Mriglobal is a 501(c)(3) non-profit research organization that specializes in scientific research, testing,...
This is a $4,415,116.56 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Mriglobal, doing business as Midwest Research Institute, to provide shelf life evaluation of investigational dosage forms. The contract does not have a small business set-aside designation. Mriglobal is an independent, not-for-profit research organization that conducts over $110 million in research annually for federal and commercial...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a non-profit research organization. The contract is valued at $949,295.00 and will run through January 31, 2026. The contract is for the evaluation of the shelf-life of samples of investigational clinical drug formulations, including parenteral, oral, and other dosage...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $92,605 firm fixed price delivery order to Mriglobal, doing business as Midwest Research Institute, an independent not-for-profit research organization. The order is part of the $100 million IDIQ contract vehicle from HHS ASPR to maintain nonclinical laboratory networks evaluating medical countermeasures. This delivery order is for ML-246 (METARRESTIN)...
The National Institutes of Health National Center for Advancing Translational Sciences awarded a $594,882 delivery order contract to Midwest Research Institute, doing business as Mriglobal, for Analytical Method Development, Validation and Stability Study of ORC-13661. This delivery order was issued against the prime contractor's master indefinite-delivery indefinite-quantity contract for Contract Research Organization Support for Drug Substance Development and Manufacture. Performance will take...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $1,596,279.92 cost-plus-fixed-fee delivery order contract to Midwest Research Institute (doing business as Mriglobal), a not-for-profit research organization, under the Drug Manufacturing and Formulation Program (DMFP) indefinite delivery/indefinite quantity (IDIQ) contract. The contract does not have a set-aside designation. Key subcontractors include the University of Iowa, which is providing research and development services related to pharmaceutical formulation and development, and Crystal Pharmatech Inc., which is supporting polymorph screening and solid-state stability work. Mriglobal, which conducts over $110 million in annual research for federal and commercial customers, has significant experience providing scientific research, testing, and product development services to HHS, the Department of Defense, and other agencies.